Innovent Biologics, Inc. (HKG:1801)
83.35
+8.50 (11.36%)
May 29, 2026, 4:08 PM HKT
Innovent Biologics Stock Forecast
Stock Price Forecast
According to 30 analysts polled by S&P Global, Innovent Biologics stock has a consensus rating of "Strong Buy" and an average price target of $117.84. The average 1-year stock price forecast is 41.38% higher than the current stock price, while the lowest is $83.41 (+0.07%) and the highest is $158.60 (+90.28%).
Price Target: $117.84 (+41.38%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Innovent Biologics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 23 | 23 | 21 | 21 | 22 | 22 |
| Buy | 4 | 4 | 4 | 5 | 5 | 5 |
| Hold | 2 | 2 | 3 | 3 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 29 | 29 | 28 | 29 | 29 | 30 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CSC Financial No rating | CSC Financial | Buy Maintains $137.51 | Buy | Maintains | $137.51 | +64.98% | May 26, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $118.30 | Buy | Maintains | $118.30 | +41.93% | May 4, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $111.00 → $113.00 | Buy | Maintains | $111.00 → $113.00 | +35.57% | May 1, 2026 |
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $118.20 | Buy | Maintains | $118.20 | +41.81% | Apr 15, 2026 |
Unknown Analyst Zhongtai Securities No rating | Zhongtai Securities | Buy Maintains $136.00 → $146.50 | Buy | Maintains | $136.00 → $146.50 | +75.76% | Apr 10, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.